Total dietary antioxidant index and survival in patients with glioblastoma multiforme

被引:11
|
作者
Il'yasova, Dora [1 ,2 ]
Marcello, Jennifer E. [3 ]
McCoy, Lucie [4 ]
Rice, Terri [4 ]
Wrensch, Margaret [4 ]
机构
[1] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Canc Ctr Biostat, Durham, NC 27705 USA
[4] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94102 USA
关键词
Epidemiology; Glioblastoma; Survival; Antioxidants; FRANCISCO BAY AREA; FOOD-FREQUENCY QUESTIONNAIRE; ADULT GLIOMA; MALIGNANT GLIOMA; BRAIN CANCER; CAPACITY; CELLS; POLYMORPHISMS; ASSOCIATION; EXPRESSION;
D O I
10.1007/s10552-009-9338-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives The role of antioxidants in survival of cancer patients is controversial. No data on the relationships between antioxidant intake and survival of glioma patients are available. Our objective was to examine such association in a large series of cases. Methods The study population includes 814 glioblastoma multiforme cases that were newly diagnosed, histologically confirmed, aged 20 or older, and residing in the San Francisco Bay Area at diagnosis. Cases were identified via the regional cancer registry's rapid case ascertainment system during 1991-1994 (series I), 1997-2000 (series II), and 2001-2004 (series III). Daily dietary antioxidant intake at diagnosis was assessed via food-frequency questionnaire and was expressed as total antioxidant index, calculated based on Trolox equivalent per gram of food. In addition, the study collected information on supplements/vitamin intake. Results Overall, our results indicated no consistent, significant association of survival with dietary antioxidant intake or its combination with vitamin supplements. However, in series III, we observed a significant association between higher antioxidant index and better survival: HR = 0.58 (95% CI: 0.46, 0.74) for each unit of antioxidant index on a log-scale. Conclusions Although it is possible that this is a chance finding, the association between dietary antioxidants and survival in the most recently recruited patients warrants further investigations.
引用
收藏
页码:1255 / 1260
页数:6
相关论文
共 50 条
  • [41] Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients
    Lu, Jie
    Cowperthwaite, Matthew C.
    Burnett, Mark G.
    Shpak, Max
    PLOS ONE, 2016, 11 (04):
  • [42] Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone
    Kappadakunnel, Melanie
    Eskin, Ascia
    Dong, Jun
    Nelson, Stanley F.
    Mischel, Paul S.
    Liau, Linda M.
    Ngheimphu, Phioanh
    Lai, Albert
    Cloughesy, Timothy F.
    Goldin, Jonathan
    Pope, Whitney B.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 96 (03) : 359 - 367
  • [43] Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme
    Kim, Young-Hoon
    Kim, Tackeun
    Joo, Jin-Deok
    Han, Jung Ho
    Kim, Yu Jung
    Kim, In Ah
    Yun, Chang-Ho
    Kim, Chae-Yong
    CANCER, 2015, 121 (17) : 2926 - 2932
  • [44] Impact of PARP-1 and DNA-PK expression on survival in patients with glioblastoma multiforme
    Kase, Marju
    Vardja, Markus
    Lipping, Agu
    Asser, Toomas
    Jaal, Jana
    RADIOTHERAPY AND ONCOLOGY, 2011, 101 (01) : 127 - 131
  • [45] No Circulating Cytomegalovirus in Five Patients with Glioblastoma Multiforme
    Lehrer, Steven
    Labombardi, Vincent
    Green, Sheryl
    Pessin-Minsley, Melissa S.
    Germano, Isabelle M.
    Rosenzweig, Kenneth E.
    ANTICANCER RESEARCH, 2011, 31 (03) : 959 - 960
  • [46] Association of pre- and post-diagnosis dietary total antioxidant capacity (TAC) and composite dietary antioxidant index (CDAI) with overall survival in patients with ovarian cancer: a prospective cohort study
    Wang, Dong-Dong
    Jia, Ming-Qian
    Xu, He-Li
    Li, Yu
    Liu, Jia-Xin
    Liu, Jia-Cheng
    Sun, Jia-Nan
    Cao, Fan
    Wu, Lang
    Liu, Fang-Hua
    Li, Yi-Zi
    Wei, Yi-Fan
    Li, Xiao-Ying
    Xiao, Qian
    Gao, Song
    Huang, Dong-Hui
    Zhang, Tao
    Gong, Ting-Ting
    Wu, Qi-Jun
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [47] Clinical and molecular models of Glioblastoma multiforme survival
    Piccolo, Stephen R.
    Frey, Lewis J.
    INTERNATIONAL JOURNAL OF DATA MINING AND BIOINFORMATICS, 2013, 7 (03) : 245 - 265
  • [48] Long-term survival with glioblastoma multiforme
    Krex, Dietmar
    Klink, Barbara
    Hartmann, Christian
    von Deimling, Andreas
    Pietsch, Torsten
    Simon, Matthias
    Sabel, Michael
    Steinbach, Joachim P.
    Heese, Oliver
    Reifenberger, Guido
    Weller, Michael
    Schackert, Gabriele
    BRAIN, 2007, 130 : 2596 - 2606
  • [49] Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions
    Cheo, Song Tao Timothy
    Lim, Gek Hsiang
    Lim, Keith Hsiu Chin
    SINGAPORE MEDICAL JOURNAL, 2017, 58 (01) : 41 - 45
  • [50] Proteins inform survival-based differences in patients with glioblastoma
    Stetson, L. C.
    Ostrom, Quinn T.
    Schlatzer, Daniela
    Liao, Peter
    Devine, Karen
    Waite, Kristin
    Couce, Marta E.
    Harris, Peggy L. R.
    Kerstetter-Fogle, Amber
    Berens, Michael E.
    Sloan, Andrew E.
    Islam, Mohammad M.
    Rajaratnam, Vilashini
    Mirza, Shama P.
    Chance, Mark R.
    Barnholtz-Sloan, Jill S.
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)